What amount sold does Cellular Logistics, Inc. report in Form D filings?

The latest linked filings report $1.1M sold across 8 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Cellular Logistics, Inc.'s most recent SEC filing?

Cellular Logistics, Inc.'s most recent Form D filing was on 2026-07-15.

How many investors does Cellular Logistics, Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Cellular Logistics, Inc. offer?

Cellular Logistics, Inc.'s SEC Form D filings indicate debt offerings.

Cellular Logistics, Inc.

CIK: 0001688621·Biotechnology·MADISON, WI·Corporation

Reported Sold

$1,070,122

Total Filings

Identified Offerings

Last Filed

Jul 15, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 15, 2026Form D — New notice

Reported sold: $50,000 · Target: $100,000

Rule 506(b)·1 investor

Apr 11, 2025Form D — New notice

Reported sold: $50,000 · Target: $350,000

Rule 506(b)·2 investors

Mar 14, 2023Form D — New notice

Reported sold: $50,000 · Target: $350,000

Rule 506(b)·2 investors

May 13, 2021Form D — New notice

Reported sold: $37,500 · Target: $37,500

Rule 506(b)·1 investor

Jun 11, 2019Form D — New notice

Reported sold: $75,000 · Target: $500,000

Rule 506(b)·3 investors

Nov 14, 2018Form D — New notice

Reported sold: $617,664 · Target: $617,664

Rule 506(b)·13 investors

Jun 27, 2017Form D — New notice

Reported sold: $4,958 · Target: $4,958

Rule 506(b)·1 investor

Nov 29, 2016Form D — New notice

Reported sold: $185,000 · Target: $500,000

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 8 identified offerings

$1,070,122

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Eric Schmuck

Related Person

Appears on 7 filings

Amish Raval

Related Person

Appears on 7 filings

Alex Vodenlich

Related Person

Appears on 5 filings

Peiman Hematti

Related Person

Appears on 3 filings

Adam Bock

Related Person

Appears on 3 filings

Paul Resnick

Related Person

Appears on 3 filings

Rakesh Soni

Related Person

Appears on 2 filings

Zach Bower

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 15, 2026	New	$100,000	$50,000	1
Apr 11, 2025	New	$350,000	$50,000	2
Mar 14, 2023	New	$350,000	$50,000	2
May 13, 2021	New	$37,500	$37,500	1
Jun 11, 2019	New	$500,000	$75,000	3
Nov 14, 2018	New	$617,664	$617,664	13
Jun 27, 2017	New	$4,958	$4,958	1
Nov 29, 2016	New	$500,000	$185,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Vertical Longevity Pharmaceuticals, Inc.

Biotechnology

Offering target: $110,000

Filed Sep 25, 2026